☰

Alessandra Matzeu, Ph.D. - Publications

Affiliations: 
 
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

24 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Illenberger JM, Flores-Ramirez FJ, Pascasio G, Matzeu A, Martin-Fardon R. Daily treatment with the dual orexin receptor antagonist DORA-12 during oxycodone abstinence decreases oxycodone conditioned reinstatement. Neuropharmacology. 239: 109685. PMID 37579870 DOI: 10.1016/j.neuropharm.2023.109685  0.76
2023 Illenberger JM, Flores-Ramirez FJ, Matzeu A, Lütjens R, Martin-Fardon R. ADX106772, an mGlu2 receptor positive allosteric modulator, selectively attenuates oxycodone taking and seeking. Neuropharmacology. 238: 109666. PMID 37463637 DOI: 10.1016/j.neuropharm.2023.109666  0.786
2023 Illenberger JM, Flores-Ramirez FJ, Matzeu A, Mason BJ, Martin-Fardon R. Suvorexant, an FDA-approved dual orexin receptor antagonist, reduces oxycodone self-administration and conditioned reinstatement in male and female rats. Frontiers in Pharmacology. 14: 1127735. PMID 37180716 DOI: 10.3389/fphar.2023.1127735  0.778
2023 McGregor R, Matzeu A, Thannickal TC, Wu F, Cornford M, Martin-Fardon R, Siegel JM. Sensitivity of Hypocretin System to Chronic Alcohol Exposure: A Human and Animal Study. Neuroscience. 522: 1-10. PMID 37121379 DOI: 10.1016/j.neuroscience.2023.04.018  0.631
2022 Flores-Ramirez FJ, Illenberger JM, Pascasio GE, Matzeu A, Mason BJ, Martin-Fardon R. Alternative use of suvorexant (Belsomra) for the prevention of alcohol drinking and seeking in rats with a history of alcohol dependence. Frontiers in Behavioral Neuroscience. 16: 1085882. PMID 36620860 DOI: 10.3389/fnbeh.2022.1085882  0.697
2022 Varodayan FP, Patel RR, Matzeu A, Wolfe SA, Curley DE, Khom S, Gandhi PJ, Rodriguez L, Bajo M, D'Ambrosio S, Sun H, Kerr TM, Gonzales RA, Leggio L, Natividad LA, et al. The Amygdala Noradrenergic System Is Compromised With Alcohol Use Disorder. Biological Psychiatry. PMID 35430085 DOI: 10.1016/j.biopsych.2022.02.006  0.639
2022 Flores-Ramirez FJ, Matzeu A, Sánchez-Marín L, Martin-Fardon R. Blockade of corticotropin-releasing factor-1 receptors in the infralimbic cortex prevents stress-induced reinstatement of alcohol seeking in male Wistar rats: Evidence of interaction between CRF and orexin receptor signaling. Neuropharmacology. 210: 109046. PMID 35341789 DOI: 10.1016/j.neuropharm.2022.109046  0.779
2022 Matzeu A, Martin-Fardon R. Understanding the Role of Orexin Neuropeptides in Drug Addiction: Preclinical Studies and Translational Value. Frontiers in Behavioral Neuroscience. 15: 787595. PMID 35126069 DOI: 10.3389/fnbeh.2021.787595  0.671
2022 Laque A, Wagner GE, Matzeu A, De Ness GL, Kerr TM, Carroll AM, de Guglielmo G, Nedelescu H, Buczynski MW, Gregus AM, Jhou TC, Zorrilla EP, Martin-Fardon R, Koya E, Ritter RC, et al. Linking drug and food addiction via compulsive appetite. British Journal of Pharmacology. PMID 35023154 DOI: 10.1111/bph.15797  0.628
2021 Matzeu A, Martin-Fardon R. Blockade of corticotropin-releasing factor receptor 1 in the central amygdala prevents cocaine-seeking behaviour induced by orexin-A administered to the posterior paraventricular nucleus of the thalamus in male rats. Journal of Psychiatry & Neuroscience : Jpn. 46: E459-E471. PMID 34318655 DOI: 10.1503/jpn.200213  0.649
2021 Matzeu A, Martin-Fardon R. Cocaine-Seeking Behavior Induced by Orexin A Administration in the Posterior Paraventricular Nucleus of the Thalamus Is Not Long-Lasting: Neuroadaptation of the Orexin System During Cocaine Abstinence. Frontiers in Behavioral Neuroscience. 15: 620868. PMID 33708078 DOI: 10.3389/fnbeh.2021.620868  0.665
2020 Matzeu A, Martin-Fardon R. Blockade of Orexin Receptors in the Posterior Paraventricular Nucleus of the Thalamus Prevents Stress-Induced Reinstatement of Reward-Seeking Behavior in Rats With a History of Ethanol Dependence. Frontiers in Integrative Neuroscience. 14: 599710. PMID 33240054 DOI: 10.3389/fnint.2020.599710  0.694
2020 Matzeu A, Martin-Fardon R. Targeting the Orexin System for Prescription Opioid Use Disorder. Brain Sciences. 10. PMID 32290110 DOI: 10.3390/Brainsci10040226  0.622
2019 Matzeu A, Martin-Fardon R. Targeting the orexin system for prescription opioid use disorder: Orexin-1 receptor blockade prevents oxycodone taking and seeking in rats. Neuropharmacology. 164: 107906. PMID 31841797 DOI: 10.1016/J.Neuropharm.2019.107906  0.707
2018 Matzeu A, Terenius L, Martin-Fardon R. Exploring Sex Differences in the Attenuation of Ethanol Drinking by Naltrexone in Dependent Rats During Early and Protracted Abstinence. Alcoholism, Clinical and Experimental Research. PMID 30320880 DOI: 10.1111/Acer.13898  0.683
2018 Matzeu A, Martin-Fardon R. Drug Seeking and Relapse: New Evidence of a Role for Orexin and Dynorphin Co-transmission in the Paraventricular Nucleus of the Thalamus. Frontiers in Neurology. 9: 720. PMID 30210441 DOI: 10.3389/Fneur.2018.00720  0.676
2018 Schmeichel BE, Matzeu A, Koebel P, Vendruscolo LF, Sidhu H, Shahryari R, Kieffer BL, Koob GF, Martin-Fardon R, Contet C. Knockdown of hypocretin attenuates extended access of cocaine self-administration in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 29703996 DOI: 10.1038/S41386-018-0054-4  0.689
2017 Matzeu A, Kallupi M, George O, Schweitzer P, Martin-Fardon R. Dynorphin Counteracts Orexin in the Paraventricular Nucleus of the Thalamus: Cellular and Behavioral Evidence. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 29052613 DOI: 10.1038/Npp.2017.250  0.686
2017 de Guglielmo G, Matzeu A, Kononoff J, Mattioni J, Martin-Fardon R, George O. Cebranopadol blocks the escalation of cocaine intake and conditioned reinstatement of cocaine seeking in rats. The Journal of Pharmacology and Experimental Therapeutics. PMID 28645915 DOI: 10.1124/Jpet.117.241042  0.676
2016 Matzeu A, Kerr TM, Weiss F, Martin-Fardon R. Orexin-A/hypocretin-1 mediates cocaine-seeking behavior in the posterior paraventricular nucleus of the thalamus via orexin/hypocretin receptor-2. The Journal of Pharmacology and Experimental Therapeutics. PMID 27540003 DOI: 10.1124/Jpet.116.235945  0.668
2015 Matzeu A, Weiss F, Martin-Fardon R. Transient inactivation of the posterior paraventricular nucleus of the thalamus blocks cocaine-seeking behavior. Neuroscience Letters. 608: 34-9. PMID 26455867 DOI: 10.1016/J.Neulet.2015.10.016  0.662
2015 Matzeu A, Cauvi G, Kerr TM, Weiss F, Martin-Fardon R. The paraventricular nucleus of the thalamus is differentially recruited by stimuli conditioned to the availability of cocaine versus palatable food. Addiction Biology. PMID 26096647 DOI: 10.1111/Adb.12280  0.647
2014 Matzeu A, Zamora-Martinez ER, Martin-Fardon R. The paraventricular nucleus of the thalamus is recruited by both natural rewards and drugs of abuse: recent evidence of a pivotal role for orexin/hypocretin signaling in this thalamic nucleus in drug-seeking behavior. Frontiers in Behavioral Neuroscience. 8: 117. PMID 24765071 DOI: 10.3389/Fnbeh.2014.00117  0.644
2014 Matzeu A, Zamora-Martinez ER, Martin-Fardon R. Involvement of mGluR5 and mGluR2/3 in drug and alcohol dependence Metabotropic Glutamate Receptors: Molecular Mechanisms, Role in Neurological Disorders and Pharmacological Effects. 151-175.  0.652
Show low-probability matches.